3622 results for «473»
3622 results
TAVI: predicting the need for permanent pacing
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to predict the need for permanent pacemaker implantation after TAVI, thanks to a selection of studies regarding novel anatomic predictors, newer MDCT measurements, and more!
Shockwave IVL: a new alternative to alternative TAVI access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn about new options for alternative TAVI access to cope with most challenges, as well as various approaches to patient selection. Gain insight also into how intravascular lithotripsy may be an option to preserve transfemoral TAVI, with a selection of clinical cases and...
Challenging clinical scenarios in valve interventions - Hosted by Germany, Spain and Singapore
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various challenging clinical cases and complications in valve interventions, such as MitraClip for cardiogenic shock, repositionning of a dislodged ALLEGRA transcatheter aortic valve, delayed coronary obstruction, percutaneous closure of a posterior leaflet perforation, and more!
Increasing safety in complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to review the current data on cerebral embolic protection during TAVI, to learn about different options for complex TAVI procedures and to discover future options for transcatheter mitral valve repair, thanks to a selection of various studies and challenging clinical cases.
Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...
GulfPCR-GIM 2019 Award and Closing Ceremony
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.
Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.
Novel approach in the management of severely calcified lesions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session dedicated to the Diamondback 360 coronary orbital atherectomy system to learn more about how this tool optimise the outcomes for coronary lesion preparation, how orbital atherectomy may fit into your daily practice, and what is the "must have" tool box for calcified coronary lesions.
Updates in TAVI therapies
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.
All you need to know to start optimising outcomes in PCI: OCT and physiology
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...
Shaping the future of transcatheter valve interventions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.
Improving patient access and clinical outcomes for valvular heart disease
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.
What will be relevant for TAVI assessment in 2020?
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about what will be relevant for TAVI assessment in 2020: key imaging requirements before referral to the Heart Team, which patients may need a pacemaker and when it should be implanted, how modern Heart Teams should function, and more!
No flow!
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the management of no-reflow (particularly following PCI or coronary stenting), thanks to a selection of compelling cases.
Management of left main bifurcation restenosis
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to manage and treat left main bifurcation restenosis efficiently, whether it be the main branch, the circumflex, or the diffuse bifurcation restenosis.
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal
23 May 2019 – From EuroPCR 2019
Consult this session to discover the essential papers from the EuroIntervention Journal and the European Heart Journal in 2019, regarding hypertension, coronary interventions, and more!
What every interventional cardiologist should know about new cardiovascular drugs
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about the impact of new cardiovascular drugs in patients with coronary artery disease, diabetes and other high-risk conditions, such as PCSK9 and SGLT-2 inhibitors, GLP1 agonists, and more!
How to deal with thrombus during PCI for STEMI - Part 2
22 May 2019 – From EuroPCR 2019
Consult this session to learn innovative techniques and tools to efficiently deal with thrombus during PCI for STEMI, thanks to a selection of captivating cases: thrombus withdrawal in coronary bifurcation through a neurovascular thrombectomy device, stentless strategy using excimer laser and thrombus aspiration for STEMI with essential...
Developing a successful CTO Programme
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to develop a successful CTO programme, while understanding the patient benefits of a CTO and maintaining radiation safety for staff and patient.
